Prof. Panayiotis Mavroidis

Department of Radiation Oncology, Division of Medical Physics

University of Texas Health Sciences Center at San Antonio

Assistant Professor

Department of Oncology-Pathology, Division of Medical Radiation Physics

Karolinska Institutet and University of Stockholm

Associate Professor (Docent)

Email: Mavroidis@uthscsa.edu

Qualifications

2002  Ph.D., Karolinska Institutet, Sweden, Medical Radiation Physics

2001  Ph.Lic., University of Stockholm, Sweden, Medical Radiation Physics

1996  M.Sc., University of Patras, Greece, Medical Physics

1994  B.Sc., University of Patras, Greece, Physics

Publications

1. P. Mavroidis, C. Kappas and B.K. Lind 1997 A computer program for evaluating the probability of complication-free tumor control incorporated in a commercial treatment planning system. J. BUON 3, 257-64.
2. B.K. Lind, P. Mavroidis, S. Hyödynmaa and C. Kappas 1999 Optimization of the dose level for a given treatment plan to maximize the complication free tumor cure. Acta Oncol. 38, 787-98.
3. P. Mavroidis, B.K. Lind, J. Van Dijk, K. Koedooder, W. De Neve, C. De Wagter, B. Planskoy, J.C. Rosenwald, B. Proimos, C. Kappas, C. Danciu, M. Benassi, G. Chierego and A. Brahme 2000 Comparison of conformal radiation therapy techniques within the dynamic radiotherapy project ‘DYNARAD’. Phys. Med. Biol. 45, 2459-81.
4. P. Mavroidis, B.K. Lind and A. Brahme 2001 Biologically effective uniform dose for specification, report and comparison of dose response relations and treatment plans. Phys. Med. Biol. 46, 2607-30.
5. P. Mavroidis, B.K. Lind and A. Brahme 2002 BEUD, an effective uniform dose linked to the probability of response. Phys. Med. Biol. 47, L3-9.
6. P. Mavroidis, K. Theodorou, D. Lefkopoulos, F. Nataf, M. Schlienger, B. Karlsson, I. Lax, C. Kappas, B.K. Lind and A. Brahme 2002 Prediction of AVM obliteration after stereotactic radiotherapy using radiobiological modelling. Phys. Med. Biol. 47, 2471-94.
7. P. Mavroidis, S. Axelsson, S. Hyödynmaa, J. Rajala, M.A. Pitkänen, B.K. Lind and A. Brahme 2002 Effects of positioning uncertainty and breathing on dose delivery and radiation pneumonitis prediction in breast cancer. Acta Oncol. 41, 471-85.
8. G. Laurell, T. Kraepelien, P. Mavroidis, B.K. Lind, J.O. Fernberg, M. Beckman and M.G. Lind 2003 Stricture of the proximal esophagus in head and neck carcinoma patients after radiotherapy. Cancer 97, 1693-700.
9. P. Mavroidis, G. Laurell, T. Kraepelien, J.O. Fernberg, B.K. Lind and A. Brahme 2003 Determination and clinical verification of dose-response parameters for esophageal stricture from head and neck radiotherapy. Acta Oncol. 42, 865-81.
10. M. Al-Abany, A.R. Helgason, A.K. Ågren Cronqvist, B.K. Lind, P. Mavroidis, P. Wersäll, E. Qvanta and G. Steineck 2004 Dose to the anal sphincter region and risk of faecal leakage. Acta Oncol. 43, 117-8.
11. P. Mavroidis, B.K. Lind, K. Theodorou, G. Laurell, J.O. Fernberg, D. Lefkopoulos, C. Kappas, B.K. Lind and A. Brahme 2004 Statistical methods for clinical verification of dose-response parameters related to esophageal stricture and AVM obliteration from radiotherapy. Phys. Med. Biol. 49, 3797-816.
12. M. Al-Abany, A.R. Helgason, A.K. Ågren Cronqvist, B.K. Lind, P. Mavroidis, P. Wersäll, H. Lind, E. Qvanta and G. Steineck 2005 Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int. J. Radiat. Oncol. Biol. Phys. 61, 1035-44.
13. P. Mavroidis, M. Al-Abany, A.R. Helgason, A.K. Ågren Cronqvist, P. Wersäll, K. Theodorou, C. Kappas, H. Lind, B.K. Lind, G. Steineck and A. Brahme 2005 Dose-response relations for anal sphincter regarding faecal leakage and blood or phlegm in stools after radiotherapy for prostate cancer. Strahlenterapie und Onkologie 181, 293-306.
14. Ι. Tsougos, P. Mavroidis, J. Rajala, K. Theodorou, R. Järvenpää, M.A. Pitkänen, K. Holli, A.T. Ojala, B.K. Lind, S. Hyödynmaa and C. Kappas 2005 Evaluation of dose-response models and parameters predicting radiation induced pneumonitis using clinical data from breast cancer radiotherapy. Phys. Med. Biol. 50, 3535-54.
15. Ι. Tsougos, P. Mavroidis, K. Theodorou, J. Rajala, M.A. Pitkänen, K. Holli, A.T. Ojala, S. Hyödynmaa, R. Järvenpää, B.K. Lind and C. Kappas 2006 Clinical validation of the LKB model and parameter sets for predicting radiation-induced pneumonitis from breast cancer radiotherapy. Phys. Med. Biol. 51, L1-9.
16. P. Mavroidis, B. Costa Ferreira, Ν. Papanikolaou, R. Svensson, C. Kappas, B.K. Lind and A. Brahme 2006 Assessing the difference between planned and delivered intensity-modulated radiotherapy dose distributions based on radiobiological measures. Clin. Oncol. 18, 529-38.
17. P. Mavroidis, G.A. Plataniotis, M. Adamus-Górka and B.K. Lind 2006 Comments on ‘Reconsidering the definition of a dose–volume histogram’—dose–mass histogram (DMH) versus dose–volume histogram (DVH) for predicting radiation-induced pneumonitis. Phys. Med. Biol. 51, L43-50.
18. Ι. Tsougos, P. Nilsson, K. Theodorou, Ε. Κjéllen, Sven-Börje Ewers, Olof Jarlman, B.K. Lind, C. Kappas and P. Mavroidis2007 NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy. Phys. Med. Biol 52, 1055-73.
19. P. Mavroidis, B. Costa Ferreira, C. Shi, B.K. Lind and N. Papanikolaou 2007 Treatment plan comparison between Helical Tomotherapy and MLC-based IMRT using radiobiological measures. Phys. Med. Biol. 52, 3817-36.
20. P. Mavroidis, B. Costa Ferreira, C. Shi, B.K. Lind and N. Papanikolaou 2008 Comparison of the 3D-Conformal, Helical Tomotherapy and MLC-based IMRT radiation modalities using radiobiological measures. J. BUON 13, 75-86.

Profile Details

http//www.uthscsa.edu, www.ki.se